MRNA Stock Dip: Biotech’s Volatile Dance with Innovation
Moderna’s stock recently dropped 6.5%, yet remains a ‘biotech stock to watch,’ highlighting the inherent volatility and speculative nature of the innovative healthcare sector.
Moderna’s stock recently dropped 6.5%, yet remains a ‘biotech stock to watch,’ highlighting the inherent volatility and speculative nature of the innovative healthcare sector.
Global markets react to US midterm elections, with KOSPI plunging and AI stocks facing scrutiny as investors reassess tech spending and sector rotation.
CVS Health plans to split its retail pharmacy business into two public companies by 2028, a major strategic shift in the healthcare industry.
Explore the enduring appeal and complex dynamics of the India-Pakistan rivalry, from record-breaking sports viewership to geopolitical undercurrents.
Afghanistan and Zimbabwe clash in a pivotal Test series in the UAE, offering both nations a vital platform to assert their presence in international cricket and vie for a World Test Championship spot.